← Back to SUPN

SUPERNUS PHARMACEUTICALS INC financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 03/08/2026Mar 2026Filed 03/08/2026Sep 2025Filed 06/11/2025Jun 2025Filed 03/08/2026Mar 2025Filed 03/08/2026Sep 2024Filed 06/11/2025Jun 2024Filed 06/11/2025Mar 2024Filed 06/11/2025
$219$208$192$165$150$176$168$144
−$58−$2.3−$45$22−$12$38$20$0.1
−$1.01−$0.04−$0.80$0.40−$0.21$0.69$0.36$0.00
5858575756565656

Trend

Revenue

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.